Genell L. Knatterud

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis

Robert P. Baughman, Alvin S. Teirstein, Marc A. Judson et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 1.8K citations

Medicine, Dermatology, Pathology +7

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

Elizabeth Ziegler, Charles J. Fisher, Charles L. Sprung et al. · New England Journal of Medicine · 1991 · 1.6K citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

Anupama Rao, Craig M. Pratt, Andrew Berke et al. · Journal of the American College of Cardiology · 1988 · 988 citations

Medicine, Cardiology, Pharmacology +17

A Case Control Etiologic Study of Sarcoidosis

Lee S. Newman, Cecile S. Rose, Eddy A. Bresnitz et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 799 citations

Public Health, Health Sciences, Epidemiologic Methods +16